Because TME interactions fuel various survival axes and downstream NFκB activation in CLL cells (3), we sought to evaluate the antileukemic effects of SpiD3 under stimulation by TME mimetics. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.